Viridian Capital Advisors

Significant tax benefits are anticipated for the cannabis industry, following President Joe Biden's confirmation of the administration's intent to reschedule cannabis from Schedule I to Schedule III. This move could alleviate the burdens of IRS tax code 280e, which has prevented cannabis...

Cannabis equity analysts may need to revise their 2024 earnings estimates after first-quarter results from major multi-state operators (MSOs). According to a recent report by Viridian Capital Advisors, 10 MSOs surpassed EBITDA estimates by $37 million in the first quarter of 2024, indicating...

In the latest report from Viridian Capital Advisors, investment trends in the U.S. cannabis industry show a marked decrease, despite significant capital inflows in leading states such as California, New York and Massachusetts. Over the last twelve months (LTM) ending May 3, 2024, there has...

As the cannabis industry adapts to its new regulatory environment following the DEA's announcement it would move to reschedule cannabis, a recent report from Viridian Capital Advisors suggests a significant uptick in mergers and acquisitions (M&A) activity is on the horizon....

The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations of multi-state operators (MSOs). According to Viridian Capital Advisors' latest weekly credit report, the MSO index surged by 25% immediately after the announcement,...

How do we look at cannabis companies' cash flow? What is their total value and what methods are used to assess their worth? A new report from Viridian Capital Advisors sheds light on how these factors interact to influence the valuations of public cannabis companies by analyzing cash...

Recent insights from Viridian Capital Advisors shed light on the bewildering trends in cannabis stocks. Year-to-date (YTD) data indicates that U.S. multi-state operators (MSOs) and Canadian licensed producers (LPs) have experienced drastically different fates. At a glance, U.S. MSOs show an average...

A recent report by Viridian Capital Advisors explores the valuation and growth prospects of cannabis stocks against those of well-established sectors like alcohol, tobacco, pharmaceuticals, healthcare products and food. The report looks closely at the value and growth of...

In the spotlight of Viridian Capital Advisors' latest Weekly Valuation Report are 16 Tier 2 and 3 U.S. cultivation and retail cannabis companies, each boasting market capitalizations between $10 million and $200 million. This deep dive into the sector, amidst a notably quiet week for equity...

Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal Tracker has become an indispensable tool for companies, investors and acquirers in the cannabis...

A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicating both advancements and setbacks in the sector. Despite an overall increase in average daily dollar trading volume, some of the industry's giants are facing...

MGO and Viridian Capital Advisors have joined forces to launch the Cannabis Capital Markets report. This comprehensive analysis, set to be unveiled in a live webinar titled "What's in Store for Cannabis Capital Markets?" on Tuesday, February 20, 2024, aims to shed light on the...

As the cannabis industry continues to blossom, it becomes increasingly important to spotlight those at the forefront of the green revolution. In this evolving landscape, visionaries are emerging, shaping the industry, societal perceptions and legal frameworks. Here are the stories and...

In a comprehensive report by Viridian Capital Advisors, the spotlight is on the valuations of companies within the U.S. cultivation and retail sector, specifically those boasting market caps ranging from $100 million to $500 million —commonly referred to as ‘Tier 2’ enterprises....

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) announced on Friday the filing of amended federal tax returns with refund claims for several of the company's business entities for 2019, 2020 and 2021. The medical cannabis giant is claiming a refund of $143 million from taxes paid,...